What’s New

FREQUENTLY ASKED QUESTIONS: COVID-19 VACCINE SIDE-EFFECTS

The textbook definition of a vaccine is a substance used to stimulate the production of antibodies that provide immunity against one or several diseases, and is prepared from the causative agent of the disease. Vaccines are considered a feat of medical science that have saved millions of lives across the globe, and in the time […]

FREQUENTLY ASKED QUESTIONS: COVID-19 VACCINE SIDE-EFFECTS Read More »

COVID-19 UPDATE: NEW VARIANTS DETECTED IN SOUTH AFRICA

MEDIA STATEMENT The National Institute for Communicable Diseases (NICD), a division of the National Health Laboratory Service, have sequenced COVID-19 specimens from individuals with a recent travel history to India. The institute can confirm that five of the specimens tested positive for B.1.617.2 (three cases from Gauteng and two from KwaZulu-Natal). The B.1.617.2 variant is

COVID-19 UPDATE: NEW VARIANTS DETECTED IN SOUTH AFRICA Read More »

COVID-19 VARIANT IN INDIA

The National Institute for Communicable Diseases (NICD), a division of the National Health Laboratory Service, continues to monitor COVID-19 trends both nationally and abroad. India has recently made headlines, following a resurgence of COVID-19 cases attributed in part to circulation of different variants, including the B.1.617 coronavirus variant. “The institution has tremendous empathy for the

COVID-19 VARIANT IN INDIA Read More »

COVID-19: UPDATE ON NORTHERN CAPE, NORTH WEST AND FREE STATE

Media Statement The National Institute for Communicable Diseases (NICD), a division of the National Health Laboratory Service, continues to monitor COVID-19 trends nationally. We have noted an upsurge in cases in the Northern Cape, North West and Free State Provinces. “The team is working with the respective provinces to ascertain whether the rise in cases

COVID-19: UPDATE ON NORTHERN CAPE, NORTH WEST AND FREE STATE Read More »

The NICD Conducts Healthcare Utilisation and COVID-19 Seroprevalence Survey

The National Institute for Communicable Diseases (NICD), together with research partners Perinatal HIV Research Unit (PHRU), Epicentre, and Genesis Analytics, are currently conducting a survey on Healthcare Utilisation and Seroprevalence of COVID-19 in three districts in South Africa, referred to as the HUTS survey. The NICD has been monitoring respiratory diseases, such as influenza and

The NICD Conducts Healthcare Utilisation and COVID-19 Seroprevalence Survey Read More »

Dominance of the SARS-CoV-2 501Y.V2 lineage in Gauteng

The SARS-CoV-2 501Y.V2 lineage has been recently been shown to predominate in the Eastern Cape, Western Cape and KwaZulu-Natal provinces of South Africa, all of which experienced major outbreaks of COVID-19. This variant of concern harbours mutations associated with increased transmissibility and neutralizing antibody resistance. In this report, we describe a preliminary analysis of 479 sequences

Dominance of the SARS-CoV-2 501Y.V2 lineage in Gauteng Read More »

Can I be re-infected with the new variant if I’ve had COVID-19?

Can you be re-infected with the new variant if you have already had COVID-19 from one of the older variants? People who have recovered from SARS-CoV-2 infection are usually protected from being infected a second time (called re-infection). This is because they develop neutralizing antibodies that remain in their blood for at least 5-6 months,

Can I be re-infected with the new variant if I’ve had COVID-19? Read More »

Scroll to Top